Tag: Metabolic Research

Research on metabolic signaling peptides including Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide.

Posted on by — Leave a comment

Tesofensine Research Overview: 5 Proven Appetite Signaling Mechanisms

Tesofensine Research Overview - research compound vial

For research use only. All peptides referenced are research chemicals not approved by the FDA for human use. Not for human consumption.

This Tesofensine Research Overview examines Tesofensine, a triple monoamine reuptake inhibitor originally developed for neurodegenerative disease research before its appetite-suppressing effects became a focus of metabolic and obesity-related research models. Tesofensine inhibits reuptake of serotonin, noradrenaline, and dopamine, distinguishing it from single-target compounds studied in similar research contexts.

Tesofensine Research Overview: Background & Discovery

Tesofensine was originally investigated in neurological research programs targeting Parkinson’s and Alzheimer’s disease models. During early research phases, investigators observed unexpected appetite-suppressing and weight-reducing effects in study subjects, which redirected substantial laboratory interest toward its central nervous system appetite signaling properties.

Research Areas & Mechanisms

This Tesofensine Research Overview highlights several mechanisms explored in laboratory research:

  • Triple monoamine reuptake inhibition: Laboratory models have examined Tesofensine’s simultaneous effect on serotonin, noradrenaline, and dopamine transporters.
  • Appetite signaling: Animal studies have investigated hypothalamic appetite regulation pathways affected by Tesofensine administration.
  • Energy expenditure research: Some laboratory models have examined whether Tesofensine influences resting metabolic rate alongside appetite suppression.
  • Dopaminergic pathway studies: Neuroscience research has explored Tesofensine’s dopamine reuptake inhibition in reward and motivation circuit models.
  • Comparative obesity research: Researchers have studied Tesofensine against other appetite-modulating compounds to compare relative effect sizes in animal models.

Across these research areas, Tesofensine is generally studied as a centrally-acting appetite modulator rather than a peripheral metabolic agent.

Tesofensine vs. AOD-9604 in Research Context

Tesofensine and AOD-9604 are both referenced in metabolic and weight-related research, but they act through distinct pathways. Tesofensine research centers on central nervous system monoamine signaling and appetite regulation, while AOD-9604 research focuses on peripheral lipolysis pathways derived from growth hormone fragment biology. Researchers studying weight-related mechanisms often reference both compounds when comparing central versus peripheral research models.

Laboratory Handling

Tesofensine is typically supplied in research-grade form and should be stored according to supplier documentation, generally in a cool, dry environment protected from light. Researchers should consult current handling documentation for the specific formulation supplied, and avoid unnecessary exposure to moisture or temperature fluctuations.

Source Tesofensine from Iron Labs

Iron Labs Tesofensine is supplied with third-party COA documentation, including purity and identity confirmation, to support research reproducibility. Source Tesofensine for your research → Iron Labs Research Catalog

Frequently Referenced Research Questions

Is Tesofensine a peptide? No. Unlike most compounds referenced in this research library, Tesofensine is a small-molecule triple monoamine reuptake inhibitor rather than a peptide chain.

Why is Tesofensine studied alongside peptide-based metabolic research? Researchers frequently reference it in comparative literature examining central versus peripheral approaches to appetite and metabolic regulation.

This Tesofensine Research Overview will be updated as new laboratory literature becomes available to support ongoing metabolic research.

Regulatory Notice

Tesofensine is not FDA-approved for any human or veterinary therapeutic application. Iron Labs sells Tesofensine exclusively as a research chemical for use by qualified researchers and laboratories. No health, therapeutic, or cosmetic claims are made or implied. Background on monoamine reuptake inhibitor research is available via PubMed.

This Tesofensine Research Overview also notes that because the compound affects three separate monoamine systems simultaneously, researchers often approach dosing protocols conservatively in early-stage studies, monitoring cardiovascular and neurological markers closely alongside the primary appetite and metabolic endpoints under investigation.

Posted on by — Leave a comment

AOD-9604 Research Overview: 5 Proven Fat Metabolism Mechanisms

AOD-9604 Research Overview - hGH fragment research peptide vial

For research use only. All peptides referenced are research chemicals not approved by the FDA for human use. Not for human consumption.

This AOD-9604 Research Overview examines AOD-9604, a modified fragment of human growth hormone corresponding to amino acids 176-191 of the hGH sequence. This fragment retains the region of hGH associated with lipolytic (fat metabolism) activity while excluding the domains responsible for growth-promoting and insulin-resistance effects, making it a frequent subject of metabolic research.

AOD-9604 Research Overview: Background & Discovery

AOD-9604 was developed by researchers seeking to isolate the fat-metabolizing region of the human growth hormone molecule from its growth-stimulating properties. This distinction has made it a recurring reference point in laboratory literature exploring lipolysis and metabolic regulation without the broader systemic effects associated with full-length hGH research models.

Research Areas & Mechanisms

This AOD-9604 Research Overview highlights several mechanisms explored in laboratory research:

  • Lipolysis signaling: In vitro and animal studies have examined AOD-9604’s effect on triglyceride breakdown within adipocyte cell models.
  • Lipogenesis inhibition: Laboratory research has investigated its role in reducing new fat cell formation in metabolic tissue cultures.
  • Cartilage and connective tissue research: Some studies have explored AOD-9604 in models examining cartilage repair signaling, an area of ongoing laboratory interest.
  • Metabolic rate studies: Animal models have investigated whether AOD-9604 influences energy expenditure markers distinct from growth hormone pathways.
  • Receptor specificity research: Laboratory studies have examined how AOD-9604 interacts with metabolic signaling receptors without triggering IGF-1-mediated growth effects.

Across these research areas, AOD-9604 is generally studied as a metabolically-targeted fragment rather than a broad growth hormone substitute.

AOD-9604 vs. Tesofensine in Research Context

AOD-9604 and Tesofensine are both referenced in metabolic and weight-related research, but their mechanisms differ substantially. Tesofensine research centers on monoamine reuptake inhibition and central nervous system appetite signaling. AOD-9604 research instead focuses on peripheral lipolysis pathways derived from growth hormone fragment biology, making the two compounds complementary reference points across central versus peripheral metabolic research models.

Laboratory Handling

AOD-9604 is typically supplied as a lyophilized powder and should be stored at -20°C prior to reconstitution. Once reconstituted with bacteriostatic water, store refrigerated at 2-8°C and use within 14-21 days for research consistency. Avoid repeated freeze-thaw cycles and extended light exposure.

Source AOD-9604 from Iron Labs

Iron Labs AOD-9604 is supplied as lyophilized powder accompanied by third-party COA documentation, including HPLC purity and mass spectrometry identity confirmation, to support research reproducibility. Source AOD-9604 for your research → Iron Labs Research Catalog

Frequently Referenced Research Questions

Is AOD-9604 the same as HGH? No. AOD-9604 is a small fragment corresponding to a specific region of the HGH molecule and does not replicate the full hormone’s growth-promoting or IGF-1-stimulating activity.

Why is AOD-9604 studied separately from growth hormone secretagogues? Researchers reference it separately because its mechanism is tied to a specific lipolytic fragment rather than stimulating endogenous hormone release, distinguishing it from compounds like Ipamorelin or CJC-1295 in comparative literature.

This AOD-9604 Research Overview will be updated as new laboratory literature becomes available to support ongoing metabolic peptide research.

Regulatory Notice

AOD-9604 is not FDA-approved for any human or veterinary therapeutic application. Iron Labs sells AOD-9604 exclusively as a research chemical for use by qualified researchers and laboratories. No health, therapeutic, or cosmetic claims are made or implied. Background on growth hormone fragment research is available via PubMed.

This AOD-9604 Research Overview also notes that researchers frequently pair fragment-based metabolic peptides with broader dietary or exercise-based experimental models to help isolate the specific contribution of the peptide from other confounding metabolic variables in animal studies.

Posted on by — Leave a comment

Semaglutide Research Overview: GLP-1 Receptor Signaling & Metabolic Biology

For research use only. Semaglutide is not approved by the FDA for use in this research chemical context and is sold by Iron Labs exclusively for laboratory research. Not for human consumption.

Semaglutide in Research Context

Semaglutide is a long-acting GLP-1 receptor agonist that has become one of the most extensively studied synthetic peptides in metabolic biology over the past decade. Its molecular architecture — a 31-amino acid sequence with fatty acid conjugation at lysine-26 — enables albumin binding that produces a half-life of approximately 7 days in human pharmacokinetic studies. For research purposes, Semaglutide’s extended pharmacokinetic profile and well-characterized receptor binding makes it a valuable tool in GLP-1 pathway studies.

GLP-1 Receptor Signaling: What Researchers Study

The GLP-1 receptor (GLP-1R) is a class B G protein-coupled receptor expressed in pancreatic beta cells, the hypothalamus, brainstem, heart, kidney, and several other tissues. Research using GLP-1R agonists like Semaglutide investigates:

  • Pancreatic beta-cell biology: GLP-1R activation stimulates cAMP production in beta cells, potentiating glucose-dependent insulin secretion. Research has examined downstream PKA and EPAC signaling pathways in cell culture and animal models.
  • Central appetite signaling: Hypothalamic and brainstem GLP-1R expression is implicated in satiety signaling. Animal research has examined how GLP-1R agonists influence food intake behavior, neuropeptide Y expression, and arcuate nucleus activity.
  • Cardiovascular research: Semaglutide has been examined in cardiovascular outcome models, with research focusing on cardiac GLP-1R expression, inflammatory cytokine modulation, and endothelial function in preclinical settings.
  • Hepatic lipid metabolism: Animal models have examined Semaglutide’s effects on hepatic steatosis, triglyceride synthesis, and fatty acid oxidation pathways.
  • Kidney biology: GLP-1R is expressed in renal tubular cells; research has examined GLP-1R agonism in models of kidney inflammation and proteinuria.

Semaglutide vs. Tirzepatide in Research

Tirzepatide’s dual GIP/GLP-1 agonism has made direct comparison with single-agonist Semaglutide a major area of metabolic research interest. Studies comparing both compounds in preclinical models have examined receptor occupancy, downstream signaling depth, and adipose tissue response. The addition of GIP receptor agonism in Tirzepatide appears to produce additive or synergistic metabolic effects in animal models, though the precise mechanisms continue to be studied.

Laboratory Handling

Semaglutide is supplied as lyophilized powder. Reconstitute with bacteriostatic water. Store lyophilized stock at -20°C; reconstituted solution at 2–8°C protected from light. Use within 28 days of reconstitution. Semaglutide is sensitive to light degradation due to its fatty acid conjugation.

Source Semaglutide for your research → Iron Labs Research Catalog

Regulatory Notice

Semaglutide sold by Iron Labs is a research chemical for laboratory use only. It is not sold or intended for human therapeutic use. Iron Labs makes no health, weight loss, or metabolic claims. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.

Posted on by — Leave a comment

MOTS-C Research Overview: Mitochondrial Peptide Science & Metabolic Biology

For research use only. MOTS-C is not approved by the FDA for human use and is sold exclusively as a research chemical. Not for human consumption.

What Is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrial-derived peptide (MDP) encoded within the 12S ribosomal RNA gene of the mitochondrial genome. It was first identified and characterized in 2015 by researchers at the University of Southern California, making it one of the more recently discovered peptides in metabolic biology research. Unlike most peptides, MOTS-C is mitochondrially encoded rather than nuclear-encoded, placing it in a novel class of signaling molecules with unique research implications.

MOTS-C in Metabolic Research

MOTS-C has generated significant interest in metabolic biology and longevity research since its discovery. Key research areas include:

  • Insulin sensitivity models: The original 2015 paper demonstrated that MOTS-C regulates insulin sensitivity in skeletal muscle cells, with observations on AMPK pathway activation and glucose uptake in in vitro models.
  • Exercise biology: Research has examined MOTS-C as an “exercise mimetic,” with animal studies showing that MOTS-C administration produced metabolic adaptations similar to physical exercise, including increased mitochondrial biogenesis markers.
  • Aging and longevity research: Studies have investigated MOTS-C levels in aging populations and animal models, with observations suggesting that circulating MOTS-C levels decline with age and that supplementation may influence healthspan markers in rodent models.
  • Obesity and adipose tissue biology: Animal research has examined MOTS-C in diet-induced obesity models, with observations on fat accumulation, energy expenditure, and inflammatory cytokine expression in adipose tissue.
  • Nuclear translocation: Notably, research has demonstrated that MOTS-C can translocate from mitochondria to the cell nucleus in response to metabolic stress, where it modulates nuclear gene expression — an unusual mechanism for a mitochondrially-encoded peptide.

MOTS-C vs. Epitalon: Longevity Research Context

Both MOTS-C and Epitalon appear in longevity-focused research literature, but through entirely different mechanisms. MOTS-C research centers on mitochondrial signaling, AMPK activation, and metabolic regulation. Epitalon research focuses on telomerase activity and pineal biology. Researchers studying biological aging often examine both in parallel to address different hallmarks of the aging process.

Laboratory Handling

MOTS-C is supplied as lyophilized powder. Store at -20°C; reconstitute with bacteriostatic water. Reconstituted solution stable at 2–8°C for up to 28 days. Protect from light and repeated freeze-thaw cycles.

Source MOTS-C for your research → Iron Labs Research Catalog

Regulatory Notice

MOTS-C is not FDA-approved for any human or veterinary use. Iron Labs sells MOTS-C exclusively as a research chemical. No health, anti-aging, or metabolic claims are made or implied.

Posted on by — Leave a comment

Metabolic Peptide Research Overview: GLP-1, Incretin & Amylin Pathways

For research use only. The peptide classes discussed on this page are described strictly as research compounds and laboratory reagents. Iron Labs makes no therapeutic claims and these materials are sold exclusively for in-vitro and preclinical laboratory research.

The Science of GLP-1 Receptor Research

Glucagon-like peptide-1 (GLP-1) is an incretin hormone naturally secreted from intestinal L-cells in response to nutrient intake. Its receptor, GLP-1R, is expressed across multiple tissue types including the pancreas, brain, heart, and kidneys, making it a target of substantial academic and pharmaceutical research interest. The development of synthetic GLP-1 receptor agonist peptides has been one of the most significant areas of metabolic biology research over the past two decades.

Key Peptide Classes Under Research

Long-Acting GLP-1 Receptor Agonists

Long-acting GLP-1 receptor agonist peptides are engineered with fatty acid side chains that promote albumin binding, extending plasma half-life in research models. These analogs have been studied extensively in the context of pancreatic beta-cell function, central appetite signaling pathways, and cardiovascular biomarker research. Their molecular structures often incorporate amino acid substitutions at GLP-1 positions 8 and 34 to resist DPP-4 degradation.

Dual GIP/GLP-1 Receptor Agonists

Dual GIP/GLP-1 receptor agonist peptides represent a newer class of metabolic research compound. Their dual-agonist mechanism has generated substantial research interest due to observed additive effects on insulin secretion pathways and appetite-regulating neuronal circuits in preclinical models. Studies have examined their influence on adipose tissue biology, hepatic lipid metabolism, and energy expenditure signaling.

Amylin Analog Peptides

Long-acting amylin analog peptides are studied in combination with incretin pathway compounds in laboratory research settings. Amylin receptors are expressed in the central nervous system and play a role in satiety signaling research, distinct from GLP-1 pathways but often co-investigated in metabolic biology studies.

Research Applications Overview

Peptide ClassReceptor Target(s)Primary Research AreasTypical Half-Life
Long-acting GLP-1 agonistGLP-1RMetabolic signaling, beta-cell biology~7 days
Dual incretin agonistGLP-1R + GIPRDual incretin pathways, adipose biology~5 days
Amylin analogAmylin receptorsCentral satiety signaling, combination models~7 days

Laboratory Handling Notes

Incretin-class research peptides are typically supplied as lyophilized powder. Reconstitute with bacteriostatic water using sterile technique. Store lyophilized stock at -20°C; reconstituted solutions at 2–8°C for up to 28 days. These peptides are sensitive to light and repeated freeze-thaw cycles. All Iron Labs metabolic research peptides include COA documentation with HPLC and mass spec data.

Browse the Iron Labs metabolic research peptide catalog → Metabolic Research Catalog

Regulatory Notice

All peptides referenced in this overview are sold by Iron Labs exclusively as research chemicals for laboratory use. These compounds are not sold or intended for therapeutic application. Iron Labs makes no health claims. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.